Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Observational Study to Evaluate the Effectiveness and Safety of Cascade® Continuous Glucose Monitoring System in China: A Real World Study

NCT05038761 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT05038761
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05038761 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Observational Study to Evaluate the Effectiveness and Safety of Cascade® Continuous Glucose Monitoring System in China: A Real World Study
Lead sponsor
Bayer
Phase
Observational
Overall status
Completed
Start date
October 8, 2021
Completion date
March 21, 2022
Enrollment
76 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

continuous glucose monitoring, diabetes mellitus